Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 599

1.

Modified diffusion-weighted imaging-Alberta Stroke Program Early Computed Tomography Score including deep white matter lesions predicts symptomatic intracerebral hemorrhage following intravenous thrombolysis.

Tanaka K, Matsumoto S, Furuta K, Yamada T, Nagano S, Takase KI, Hatano T, Yamasaki R, Kira JI.

J Thromb Thrombolysis. 2019 Nov 19. doi: 10.1007/s11239-019-01979-7. [Epub ahead of print]

PMID:
31745858
2.

Immune-Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders with Advanced Non-Small Cell Lung Cancer.

Akamatsu H, Murakami E, Oyanagi J, Shibaki R, Kaki T, Takase E, Tanaka M, Harutani Y, Yamagata N, Okuda Y, Furuta K, Sugimoto T, Teraoka S, Hayata A, Tokudome N, Ozawa Y, Mori K, Koh Y, Yamamoto N.

Oncologist. 2019 Nov 19. pii: theoncologist.2019-0299. doi: 10.1634/theoncologist.2019-0299. [Epub ahead of print]

PMID:
31744931
3.

A Visual Task Management Application for Acute Ischemic Stroke Care.

Matsumoto S, Koyama H, Nakahara I, Ishii A, Hatano T, Ohta T, Tanaka K, Ando M, Chihara H, Takita W, Tokunaga K, Hashikawa T, Funakoshi Y, Kamata T, Higashi E, Watanabe S, Kondo D, Tsujimoto A, Furuta K, Ishihara T, Hashimoto T, Koge J, Sonoda K, Torii T, Nakagaki H, Yamasaki R, Nagata I, Kira JI.

Front Neurol. 2019 Oct 30;10:1118. doi: 10.3389/fneur.2019.01118. eCollection 2019.

4.

Forkhead Box M1 Transcription Factor Drives Liver Inflammation Linking to Hepatocarcinogenesis in Mice.

Kurahashi T, Yoshida Y, Ogura S, Egawa M, Furuta K, Hikita H, Kodama T, Sakamori R, Kiso S, Kamada Y, Wang IC, Eguchi H, Morii E, Doki Y, Mori M, Kalinichenko VV, Tatsumi T, Takehara T.

Cell Mol Gastroenterol Hepatol. 2019 Oct 24. pii: S2352-345X(19)30144-4. doi: 10.1016/j.jcmgh.2019.10.008. [Epub ahead of print]

5.

Integrin β1-enriched extracellular vesicles mediate monocyte adhesion and promote liver inflammation in murine NASH.

Guo Q, Furuta K, Lucien F, Gutierrez Sanchez LH, Hirsova P, Krishnan A, Kabashima A, Pavelko KD, Madden B, Alhuwaish H, Gao Y, Revzin A, Ibrahim SH.

J Hepatol. 2019 Dec;71(6):1193-1205. doi: 10.1016/j.jhep.2019.07.019. Epub 2019 Aug 6.

PMID:
31433301
6.

Efficacy and safety of glecaprevir/pibrentasvir as retreatment therapy for patients with genotype 2 chronic hepatitis C who failed prior sofosbuvir plus ribavirin regimen.

Kusakabe A, Kurosaki M, Itakura J, Joko K, Akahane T, Tsuji K, Kobashi H, Sohda T, Kimura H, Narita R, Furuta K, Izumi N.

Hepatol Res. 2019 Oct;49(10):1121-1126. doi: 10.1111/hepr.13387. Epub 2019 Jul 10.

PMID:
31209976
7.

Retained Rice Cake: A Unique Upper Gastrointestinal Foreign Body: Case Report and a Literature Review.

Oka A, Ishihara S, Mikami H, Sonoyama H, Mishiro T, Tobita H, Kawashima K, Miyake T, Ishimura N, Furuta K, Kinoshita Y, Nishina M.

Intern Med. 2019 Sep 1;58(17):2485-2494. doi: 10.2169/internalmedicine.2760-19. Epub 2019 Jun 7.

8.

Monitoring of cancer patients via next-generation sequencing of patient-derived circulating tumor cells and tumor DNA.

Onidani K, Shoji H, Kakizaki T, Yoshimoto S, Okaya S, Miura N, Sekikawa S, Furuta K, Lim CT, Shibahara T, Boku N, Kato K, Honda K.

Cancer Sci. 2019 Aug;110(8):2590-2599. doi: 10.1111/cas.14092. Epub 2019 Jul 23.

9.

Kinesin-6 Klp9 plays motor-dependent and -independent roles in collaboration with Kinesin-5 Cut7 and the microtubule crosslinker Ase1 in fission yeast.

Yukawa M, Okazaki M, Teratani Y, Furuta K, Toda T.

Sci Rep. 2019 May 14;9(1):7336. doi: 10.1038/s41598-019-43774-7.

10.

Real-world efficacy of elbasvir and grazoprevir for hepatitis C virus (genotype 1): A nationwide, multicenter study by the Japanese Red Cross Hospital Liver Study Group.

Mashiba T, Joko K, Kurosaki M, Ochi H, Hasebe C, Akahane T, Sohda T, Tsuji K, Mitsuda A, Kimura H, Narita R, Ogawa C, Furuta K, Shigeno M, Okushin H, Ito H, Kusakabe A, Satou T, Kawanami C, Nakata R, Kobashi H, Tamada T, Ide Y, Yagisawa H, Morita A, Matsushita T, Okada K, Izumi N.

Hepatol Res. 2019 Oct;49(10):1114-1120. doi: 10.1111/hepr.13362. Epub 2019 Jun 14.

PMID:
31077527
11.

Transport of microtubules according to the number and spacing of kinesin motors on gold nano-pillars.

Kaneko T, Ando S, Furuta K, Oiwa K, Shintaku H, Kotera H, Yokokawa R.

Nanoscale. 2019 May 28;11(20):9879-9887. doi: 10.1039/c9nr01324e. Epub 2019 Mar 19.

PMID:
30888373
12.

Prognostic significance of crazy paving ground grass opacities in non-HIV Pneumocystis jirovecii pneumonia: an observational cohort study.

Kumagai S, Arita M, Koyama T, Kumazawa T, Inoue D, Nakagawa A, Kaji Y, Furuta K, Fukui M, Tomii K, Taguchi Y, Tomioka H, Ishida T.

BMC Pulm Med. 2019 Feb 21;19(1):47. doi: 10.1186/s12890-019-0813-y.

13.

Suppression of IgE-Independent Degranulation of Murine Connective Tissue-Type Mast Cells by Dexamethasone.

Yamada K, Sato H, Sakamaki K, Kamada M, Okuno Y, Fukuishi N, Furuta K, Tanaka S.

Cells. 2019 Feb 1;8(2). pii: E112. doi: 10.3390/cells8020112.

14.

POGLUT1, the putative effector gene driven by rs2293370 in primary biliary cholangitis susceptibility locus chromosome 3q13.33.

Hitomi Y, Ueno K, Kawai Y, Nishida N, Kojima K, Kawashima M, Aiba Y, Nakamura H, Kouno H, Kouno H, Ohta H, Sugi K, Nikami T, Yamashita T, Katsushima S, Komeda T, Ario K, Naganuma A, Shimada M, Hirashima N, Yoshizawa K, Makita F, Furuta K, Kikuchi M, Naeshiro N, Takahashi H, Mano Y, Yamashita H, Matsushita K, Tsunematsu S, Yabuuchi I, Nishimura H, Shimada Y, Yamauchi K, Komatsu T, Sugimoto R, Sakai H, Mita E, Koda M, Nakamura Y, Kamitsukasa H, Sato T, Nakamuta M, Masaki N, Takikawa H, Tanaka A, Ohira H, Zeniya M, Abe M, Kaneko S, Honda M, Arai K, Arinaga-Hino T, Hashimoto E, Taniai M, Umemura T, Joshita S, Nakao K, Ichikawa T, Shibata H, Takaki A, Yamagiwa S, Seike M, Sakisaka S, Takeyama Y, Harada M, Senju M, Yokosuka O, Kanda T, Ueno Y, Ebinuma H, Himoto T, Murata K, Shimoda S, Nagaoka S, Abiru S, Komori A, Migita K, Ito M, Yatsuhashi H, Maehara Y, Uemoto S, Kokudo N, Nagasaki M, Tokunaga K, Nakamura M.

Sci Rep. 2019 Jan 14;9(1):102. doi: 10.1038/s41598-018-36490-1.

15.

4-Aryl-5-carbamoyl-3-isoxazolols as competitive antagonists of insect GABA receptors: Synthesis, biological activity, and molecular docking studies.

Liu G, Li H, Shi J, Wang W, Furuta K, Liu D, Zhao C, Ozoe F, Ju X, Ozoe Y.

Bioorg Med Chem. 2019 Jan 15;27(2):416-424. doi: 10.1016/j.bmc.2018.12.018. Epub 2018 Dec 12.

PMID:
30579800
16.

Azepine derivative T4FAT, a new copper chelator, inhibits tyrosinase.

Okajima S, Hamamoto A, Asano M, Isogawa K, Ito H, Kato S, Hirata Y, Furuta K, Takemori H.

Biochem Biophys Res Commun. 2019 Jan 29;509(1):209-215. doi: 10.1016/j.bbrc.2018.12.105. Epub 2018 Dec 19.

PMID:
30579605
17.

Suppression of IFN-γ Production in Murine Splenocytes by Histamine Receptor Antagonists.

Kamei M, Otani Y, Hayashi H, Nakamura T, Yanai K, Furuta K, Tanaka S.

Int J Mol Sci. 2018 Dec 17;19(12). pii: E4083. doi: 10.3390/ijms19124083.

18.

Perinatal Nutritional Reprogramming of the Epigenome Promotes Subsequent Development of Nonalcoholic Steatohepatitis.

Gutierrez Sanchez LH, Tomita K, Guo Q, Furuta K, Alhuwaish H, Hirsova P, Baheti S, Alver B, Hlady R, Robertson KD, Ibrahim SH.

Hepatol Commun. 2018 Oct 1;2(12):1493-1512. doi: 10.1002/hep4.1265. eCollection 2018 Dec.

19.

Identification of the minimal region of peptide derived from ADP-ribosylation factor1 (ARF1) that inhibits IgE-mediated mast cell activation.

Uchida R, Egawa T, Fujita Y, Furuta K, Taguchi H, Tanaka S, Nishida K.

Mol Immunol. 2019 Jan;105:32-37. doi: 10.1016/j.molimm.2018.11.002. Epub 2018 Nov 23.

PMID:
30472514
20.

Prevalence of frailty, cognitive impairment, and sarcopenia in outpatients with cardiometabolic disease in a frailty clinic.

Tamura Y, Ishikawa J, Fujiwara Y, Tanaka M, Kanazawa N, Chiba Y, Iizuka A, Kaito S, Tanaka J, Sugie M, Nishimura T, Kanemaru A, Shimoji K, Hirano H, Furuta K, Kitamura A, Seino S, Shinkai S, Harada K, Kyo S, Ito H, Araki A.

BMC Geriatr. 2018 Nov 6;18(1):264. doi: 10.1186/s12877-018-0955-4.

21.

CEACAM1 Is Associated With the Suppression of Natural Killer Cell Function in Patients With Chronic Hepatitis C.

Suda T, Tatsumi T, Nishio A, Kegasawa T, Yoshioka T, Yamada R, Furuta K, Kodama T, Shigekawa M, Hikita H, Sakamori R, Fukuhara T, Matsuura Y, Takehara T.

Hepatol Commun. 2018 Sep 25;2(10):1247-1258. doi: 10.1002/hep4.1240. eCollection 2018 Oct.

22.

Ointment vehicles regulate the wound-healing process by modifying the hyaluronan-rich matrix.

Murasawa Y, Furuta K, Noda Y, Nakamura H, Fujii S, Isogai Z.

Wound Repair Regen. 2018 Nov;26(6):437-445. doi: 10.1111/wrr.12673. Epub 2018 Oct 18.

PMID:
30252184
23.

Liver Fibrosis Is Associated With Corrected QT Prolongation During Ledipasvir/Sofosbuvir Treatment for Patients With Chronic Hepatitis C.

Tahata Y, Sakamori R, Urabe A, Morishita N, Yamada R, Yakushijin T, Hiramatsu N, Doi Y, Kaneko A, Hagiwara H, Yamada Y, Hijioka T, Inada M, Tamura S, Imai Y, Furuta K, Kodama T, Hikita H, Tatsumi T, Takehara T.

Hepatol Commun. 2018 Aug 6;2(8):884-892. doi: 10.1002/hep4.1206. eCollection 2018 Aug.

24.

Past history of hepatocellular carcinoma is an independent risk factor of treatment failure in patients with chronic hepatitis C virus infection receiving direct-acting antivirals.

Sugiura A, Joshita S, Umemura T, Yamazaki T, Fujimori N, Kimura T, Matsumoto A, Igarashi K, Usami Y, Wada S, Mori H, Shibata S, Yoshizawa K, Morita S, Furuta K, Kamijo A, Iijima A, Kako S, Maruyama A, Kobayashi M, Komatsu M, Matsumura M, Miyabayashi C, Ichijo T, Takeuchi A, Koike Y, Gibo Y, Tsukadaira T, Inada H, Kiyosawa K, Tanaka E.

J Viral Hepat. 2018 Dec;25(12):1462-1471. doi: 10.1111/jvh.12973. Epub 2018 Aug 30.

PMID:
30044517
25.

Neuromedin U directly induces degranulation of skin mast cells, presumably via MRGPRX2.

Matsuo Y, Yanase Y, Irifuku R, Takahagi S, Mihara S, Ishii K, Kawaguchi T, Tanaka A, Iwamoto K, Watanuki H, Furuta K, Tanaka S, Inoue A, Aoki J, Hide M.

Allergy. 2018 Nov;73(11):2256-2260. doi: 10.1111/all.13555. Epub 2018 Jul 29. No abstract available.

PMID:
29987892
26.

Targeting the mevalonate pathway is a novel therapeutic approach to inhibit oncogenic FoxM1 transcription factor in human hepatocellular carcinoma.

Ogura S, Yoshida Y, Kurahashi T, Egawa M, Furuta K, Kiso S, Kamada Y, Hikita H, Eguchi H, Ogita H, Doki Y, Mori M, Tatsumi T, Takehara T.

Oncotarget. 2018 Apr 20;9(30):21022-21035. doi: 10.18632/oncotarget.24781. eCollection 2018 Apr 20.

27.

Novel oxindole derivatives prevent oxidative stress-induced cell death in mouse hippocampal HT22 cells.

Hirata Y, Yamada C, Ito Y, Yamamoto S, Nagase H, Oh-Hashi K, Kiuchi K, Suzuki H, Sawada M, Furuta K.

Neuropharmacology. 2018 Jun;135:242-252. doi: 10.1016/j.neuropharm.2018.03.015. Epub 2018 Mar 15.

PMID:
29551691
28.

Nonstructural protein 5A/P32 deletion after failure of ledipasvir/sofosbuvir in hepatitis C virus genotype 1b infection.

Doi A, Hikita H, Sakamori R, Tahata Y, Kai Y, Yamada R, Yakushijin T, Mita E, Ohkawa K, Imai Y, Furuta K, Kodama T, Tatsumi T, Takehara T.

Hepatology. 2018 Jul;68(1):380-383. doi: 10.1002/hep.29836. Epub 2018 May 14. No abstract available.

PMID:
29425404
29.

Standardization and Innovation in Paving a Path to a Better Future: An Update of Activities in ISO/TC276/WG2 Biobanks and Bioresources.

Furuta K, Allocca CM, Schacter B, Bledsoe MJ, Ramirez NC.

Biopreserv Biobank. 2018 Feb;16(1):23-27. doi: 10.1089/bio.2017.0117. Epub 2018 Feb 2.

PMID:
29394084
30.

Significance of blood cultures in nursing home-acquired pneumonia.

Yamazoe M, Tomioka H, Yamashita S, Furuta K, Kaneko M.

J Infect Chemother. 2018 Apr;24(4):272-277. doi: 10.1016/j.jiac.2017.11.012. Epub 2017 Dec 29.

PMID:
29292179
31.

Hepatocellular carcinoma due to a baffle obstruction after the mustard operation: A case report.

Yoshihara T, Sakamori R, Furuta K, Shigekawa M, Yamada R, Kodama T, Hikita H, Yakushijin T, Tatsumi T, Sakata Y, Eguchi H, Sawa Y, Takehara T.

Hepatology. 2018 Jun;67(6):2471-2473. doi: 10.1002/hep.29758. Epub 2018 Apr 19. No abstract available.

PMID:
29272033
32.

Re-engineering of protein motors to understand mechanisms biasing random motion and generating collective dynamics.

Furuta K, Furuta A.

Curr Opin Biotechnol. 2018 Jun;51:39-46. doi: 10.1016/j.copbio.2017.11.009. Epub 2017 Nov 24. Review.

PMID:
29179022
33.

Synthesis of 3-Arylmethyl-2-oxindole Derivatives and Their Effects on Neuronal Cell Death.

Furuta K, Mizuno Y, Maeda M, Koyama H, Hirata Y.

Chem Pharm Bull (Tokyo). 2017;65(11):1093-1097. doi: 10.1248/cpb.c17-00627.

34.

Short- and long-term evaluation of cognitive functions after electroconvulsive therapy in a Japanese population.

Takagi S, Takeuchi T, Yamamoto N, Fujita M, Furuta K, Ishikawa H, Motohashi N, Nishikawa T.

Psychiatry Clin Neurosci. 2018 Feb;72(2):95-102. doi: 10.1111/pcn.12614. Epub 2017 Nov 29.

35.

Prevention of oxytosis-induced c-Raf down-regulation by (arylthio)cyclopentenone prostaglandins is neuroprotective.

Shibata S, Furuta K, Oh-Hashi K, Ueda H, Kiuchi K, Hirata Y.

Toxicology. 2017 Sep 1;390:83-87. doi: 10.1016/j.tox.2017.09.006. Epub 2017 Sep 6.

PMID:
28888848
36.

Synthesis of 3-[4-(dimethylamino)phenyl]alkyl-2-oxindole derivatives and their effects on neuronal cell death.

Furuta K, Kawai Y, Mizuno Y, Hattori Y, Koyama H, Hirata Y.

Bioorg Med Chem Lett. 2017 Sep 15;27(18):4457-4461. doi: 10.1016/j.bmcl.2017.08.005. Epub 2017 Aug 4.

PMID:
28807440
37.

Bleeding Risk Related to Upper Gastrointestinal Endoscopic Biopsy in Patients Receiving Antithrombotic Therapy: A Multicenter Prospective Observational Study.

Yuki T, Ishihara S, Yashima K, Kawaguchi K, Fujishiro H, Miyaoka Y, Yuki M, Kushiyama Y, Yasugi A, Shabana M, Furuta K, Tanaka K, Koda M, Hamamoto T, Sasaki Y, Tanaka H, Yoshimura T, Murawaki Y, Isomoto H, Kinoshita Y.

Curr Ther Res Clin Exp. 2017 Apr 5;84:32-36. doi: 10.1016/j.curtheres.2017.03.006. eCollection 2017.

38.

ISO/TC276/WG2 Biobanks and Bioresources: Draft International Standard Is Now Available for Comment.

Allocca CM, Bledsoe MJ, Furuta K, Ramirez NC.

Biopreserv Biobank. 2017 Aug;15(4):399-401. doi: 10.1089/bio.2017.29025.cma. Epub 2017 Jul 25. No abstract available.

PMID:
28741961
39.

Freezing of gait is an early clinical feature of progressive supranuclear palsy.

Osaki Y, Morita Y, Miyamoto Y, Furuta K, Furuya H.

Neurol Clin Neurosci. 2017 May;5(3):86-90. doi: 10.1111/ncn3.12122. Epub 2017 Apr 17.

40.

Reconstitution of the oocyte nucleolus in mice through a single nucleolar protein, NPM2.

Ogushi S, Yamagata K, Obuse C, Furuta K, Wakayama T, Matzuk MM, Saitou M.

J Cell Sci. 2017 Jul 15;130(14):2416-2429. doi: 10.1242/jcs.195875. Epub 2017 Jun 9.

41.

Frequency of, and factors associated with, hepatitis B virus reactivation in hepatitis C patients treated with all-oral direct-acting antivirals: Analysis of a Japanese prospective cohort.

Doi A, Sakamori R, Tahata Y, Urabe A, Morishita N, Yamada R, Furuta K, Kodama T, Hikita H, Yakushijin T, Ohkawa K, Kaneko A, Imai Y, Tatsumi T, Takehara T.

Hepatol Res. 2017 Dec;47(13):1438-1444. doi: 10.1111/hepr.12919. Epub 2017 Aug 1.

PMID:
28585404
42.

Glycoform of a newly identified pollen allergen, Cha o 3, from Chamaecyparis obtusa (Japanese cypress, Hinoki).

Osada T, Maeda M, Tanabe C, Furuta K, Vavricka CJ, Sasaki E, Okano M, Kimura Y.

Carbohydr Res. 2017 Aug 7;448:18-23. doi: 10.1016/j.carres.2017.05.005. Epub 2017 May 24.

PMID:
28575723
43.

Visuotactile interaction even in far sagittal space in older adults with decreased gait and balance functions.

Teramoto W, Honda K, Furuta K, Sekiyama K.

Exp Brain Res. 2017 Aug;235(8):2391-2405. doi: 10.1007/s00221-017-4975-7. Epub 2017 May 10.

PMID:
28493067
44.

Small teams of myosin Vc motors coordinate their stepping for efficient cargo transport on actin bundles.

Krementsova EB, Furuta K, Oiwa K, Trybus KM, Ali MY.

J Biol Chem. 2017 Jun 30;292(26):10998-11008. doi: 10.1074/jbc.M117.780791. Epub 2017 May 5.

45.

Structural feature of N-glycans of bamboo shoot glycoproteins: useful source of plant antigenic N-glycans.

Tanabe C, Furuta K, Maeda M, Kimura Y.

Biosci Biotechnol Biochem. 2017 Jul;81(7):1405-1408. doi: 10.1080/09168451.2017.1320519. Epub 2017 May 4.

46.

Clinical medication review tool for polypharmacy: Mapping approach for pharmacotherapeutic classifications.

Mizokami F, Mizuno T, Mori T, Nagamatsu T, Endo H, Hirashita T, Ichino T, Akishita M, Furuta K.

Geriatr Gerontol Int. 2017 Nov;17(11):2025-2033. doi: 10.1111/ggi.13014. Epub 2017 Mar 30.

PMID:
28371121
47.

Comparison of Nutritional Risk Scores for Predicting Mortality in Japanese Chronic Hemodialysis Patients.

Takahashi H, Inoue K, Shimizu K, Hiraga K, Takahashi E, Otaki K, Yoshikawa T, Furuta K, Tokunaga C, Sakakibara T, Ito Y; Tokai Renal Nutrition Study Group.

J Ren Nutr. 2017 May;27(3):201-206. doi: 10.1053/j.jrn.2016.12.005. Epub 2017 Feb 20.

PMID:
28215493
48.

Construction of a System for the Strawberry Nursery Production towards Elimination of Latent Infection of Anthracnose Fungi by a Combination of PCR and Microtube Hybridization.

Furuta K, Nagashima S, Inukai T, Masuta C.

Plant Pathol J. 2017 Feb;33(1):80-86. doi: 10.5423/PPJ.NT.05.2016.0132. Epub 2017 Feb 1.

49.

Vesicular Polyamine Transporter Mediates Vesicular Storage and Release of Polyamine from Mast Cells.

Takeuchi T, Harada Y, Moriyama S, Furuta K, Tanaka S, Miyaji T, Omote H, Moriyama Y, Hiasa M.

J Biol Chem. 2017 Mar 3;292(9):3909-3918. doi: 10.1074/jbc.M116.756197. Epub 2017 Jan 12.

50.

Katanin p80, NuMA and cytoplasmic dynein cooperate to control microtubule dynamics.

Jin M, Pomp O, Shinoda T, Toba S, Torisawa T, Furuta K, Oiwa K, Yasunaga T, Kitagawa D, Matsumura S, Miyata T, Tan TT, Reversade B, Hirotsune S.

Sci Rep. 2017 Jan 12;7:39902. doi: 10.1038/srep39902.

Supplemental Content

Loading ...
Support Center